Pulmonary alveolar proteinosis in a patient with Behcet's disease

Respirology

Volumn 14, Issue 2, 2009, Pages 305-308

  Uchiyama, Michihiro ^a,b,c   Nagao, Tsuyoshi ^d   Hattori, Aritoshi ^d   Fujii, Tatsuya ^b   Ichiwata, Toshio ^e   Nakata, Koh ^f   Tani, Kenzaburo ^g   Hayashi, Takuya ^b  

^a SHIZUOKA CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Mishuku Hospital   (Japan)

^d Self Defense Forces Central Hospital   (Japan)

^e DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIIGATA UNIVERSITY   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti granulocyte macrophage colony stimulating factor antibody; Behcet's disease; Secondary pulmonary alveolar proteinosis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; COLCHICINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; IMMUNOGLOBULIN; LEVOFLOXACIN; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; ARTICLE; BEHCET DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG ALVEOLUS PROTEINOSIS; LUNG FUNCTION TEST; LUNG LAVAGE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ANTIBODIES; BEHCET SYNDROME; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PULMONARY ALVEOLAR PROTEINOSIS;

EID: 61349104709     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01450.x     Document Type: Article

References (12)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N. Engl. J. Med. 1958 258 : 1123 42.
2. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am. J. Respir. Crit. Care Med. 2002 166 : 215 35.
3. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N. Engl. J. Med. 2003 349 : 2527 39.
4. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin. Proc. 1987 62 : 499 518.
5. Bedrossian CW, Luna MA, Conklin RH, Miller WC. Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum. Pathol. 1980 11 : 527 35.
6. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1999 190 : 875 80.
7. Rogers RM, Tantum KR. Bronchopulmonary lavage: a new approach to old problems. Med. Clin. North Am. 1970 54 : 755 71.
8. Arai T, Hamano E, Inoue Y, Ryushi T, Nukiwa T et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir. Med. 2004 98 : 1227 30.
9. Tazawa R, Hamano E, Arai T, Ohta H, Ishimoto O et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 2005 171 : 1142 9.
10. Samuels MP, Warner JO. Pulmonary alveolar lipoproteinosis complicating juvenile dermatomyositis. Thorax 1988 43 : 939 40.
11. Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 1998 158 : 1294 8.
12. Nakajima M, Manabe T, Niki Y, Matsushima T. Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis. Thorax 1998 53 : 809 11.